Effects of Brexit on Pharmaceuticals and the Biotechnology Industry

On June 24, 2016, there was a historic decision—the United Kingdom voted to leave the European Union. Following the decision, global markets experienced a shock. The United Kingdom’s prime minister, David Cameron, announced his resignation after the Brexit vote. He admitted that the country needed “fresh leadership.”

It’s important for investors to understand the possible effects of Brexit on pharmaceuticals and biotechnology companies.

More